Reactivation of latent human cytomegalovirus in CD14+ monocytes is differentiation dependent

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7543-7554

  Soderberg Naucler C ^a   Streblow, D N ^a   Fish, K N ^a   Allan Yorke, J ^a   Smith, P P ^a   Nelson, J A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REACTIVATION; VIRUS REPLICATION;

ANTIGENS, CD14; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; HUMANS; MONOCYTES; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0034899174     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7543-7554.2001     Document Type: Article

References (55)

1. A European multicenter study of chronic graft-versus-host disease: The role of cytomegalovirus serology in recipients and donors-acute graft-versus-host disease, and splenectomy
2. Transfusion-transmitted cytomegalovirus infection
3. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116)
4. Supernatural killer cells
5. Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates
6. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients
7. Cytomegalovirus infection and reinfection transmitted by heart transplantation
8. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors
9. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization
10. Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta
11. A novel mechanism for persistence of human cytomegalovirus in macrophages
12. Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages
13. Cytomegalovirus persistence in macrophages and endothelial cells
14. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus
15. Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human alveolar macrophages
16. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections
17. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells
18. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape
19. Human cytomegalovirus productively infects primary differentiated macrophages
20. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors
21. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals
22. The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts
23. Unrestricted replication of human cytomegalovirus in hydrocortisone- treated macrophages
24. Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection
25. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization
26. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor
27. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands
28. Infection of mononucleated phagocytes with human cytomegalovirus
29. Risk factors for cytomegalovirus infection after human marrow transplantation
30. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow
31. Enhancing effects of IL-2 on M-CSF production by human peripheral blood monocytes
32. Secretion of cytokines upon allogeneic stimulation: Effect of aging
33. IL-2 induces IL-6 production in human monocytes
34. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
35. Dendritic cells as the terminal stage of monocyte differentiation
36. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection
37. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels
38. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells
39. Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line
40. Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining
41. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection
42. Reactivation of human cytomegalovirus in a novel dendritic cell phenotype from healthy donors
43. IFN-γ and TNF-α specifically induce the formation of cytomegalovirus permissive monocyte-derived macrophages which are refractory to the antiviral activity of these cytokines
44. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells
45. Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region
46. Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes
47. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells
48. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells
49. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers
50. Cytomegalovirus infection as a complication of blood transfusion
51. Optimal control of interferon-gamma and tumor necrosis factor-alpha by interleukin-10 produced in response to one HLA-DR mismatch during the primary mixed lymphocyte reaction
52. Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins
53. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection
54. Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo
55. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line